Developer docs
API playgroundTry for free, no card

Search company profiles

Bay Area Lyme Foundation

Full company profile

uuid00062j5

Namestring
Bay Area Lyme Foundation
Legal namestring
Bay Area Lyme Foundation
Websiteurl
bayarealyme.org
Company typeenum
Private
Founded yearint
2012
Descriptiontext

Bay Area Lyme Foundation is a 501(c)(3) nonprofit organization founded in 2012 and headquartered in Portola Valley, California. The foundation's mission is to make Lyme disease easy to diagnose and simple to cure by funding scientific research, operating research infrastructure, and providing prevention education. It serves Lyme disease patients, researchers at academic and industry institutions, healthcare providers, and the broader public affected by tick-borne illness — a population estimated at roughly 620,000 new US cases annually, with cases reported in 65 countries.

The foundation operates a vertically integrated research-acceleration platform spanning basic science funding, biospecimen distribution, clinical trials, and commercialization. Core programs include the Lyme Disease Biobank (the nation's first, with 25,000+ samples distributed to 125 approved research projects), the Emerging Leader Award grant program (grants ranging $150,000-$300,000), the UCSF-affiliated Clinical Trials Center, the Citizen Science Free Tick Testing Program, and educational content via the Ticktective podcast and video library. Since inception, the foundation has awarded over $30M in grants across more than 100 projects at 37 institutions and enabled FDA clearance for new diagnostic tests. In 2025 the foundation launched Bay Area Lyme Ventures, an impact investment arm that made its first strategic investment in Galaxy Diagnostics in June 2026.

Revenue is generated entirely through donations, grants, and event-based fundraising, with 100% of donor contributions directed to research and prevention because the LaureL Foundation covers all administrative expenses. Annual events include LymeAid (which raised $900,000 in 2026), Polo for Lyme, and Hops & Harmony. The organization is led by co-founders Laure L. Woods and Bonnie Crater as Co-Chairs of the Board, with David A. Walsey appointed Executive Director in 2025 succeeding Linda Giampa. Key strategic partners include the LaureL Foundation, Steven and Alexandra Cohen Foundation, Project Lyme, Center for Lyme Action, and NDRI.

Short descriptiontext

Bay Area Lyme Foundation is a 501(c)(3) nonprofit founded in 2012 that funds Lyme disease research, operates the nation's first Lyme Disease Biobank, runs prevention education programs, and deploys impact investments through Bay Area Lyme Ventures to advance tick-borne disease diagnostics and therapeutics.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersPortola Valley, United States
HQ citystring
Portola Valley
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
lyme disease research, biospecimen biobank services, research grant funding, tick-borne disease prevention, nonprofit health foundation
Industry2 codes
1Health & Medical Research Grantmaking Foundations
CodeBPAGAKALPrimaryYes
2Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
CodeBPAGACAAPrimaryNo
NAICS code2 codes
  • Grantmaking Foundations813211
  • Voluntary Health Organizations813212
SIC code1 code
  • Services-Membership Organizations8600
Product category
Nonprofit Disease Research Foundation
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Donations and Grants
TypeData Monetisation
Description

Bay Area Lyme Foundation operates as a 501(c)(3) nonprofit organization funded entirely through donations and grants. Thanks to the LaureL Foundation covering administrative expenses, 100% of donor contributions go directly to research and prevention programs.

bayarealyme.org
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Others, Personnel, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 5 records shown
1Lyme Disease Biobank
Description

A biobank providing blood, urine, and tissue samples to researchers studying Lyme disease and tick-borne infections. Approaching 10-year anniversary with over 25,000 samples distributed to 125 approved research projects.

biospace.com
+4 more records
Core offering1 text field

Bay Area Lyme Foundation is a 501(c)(3) nonprofit foundation that funds Lyme disease research, distributes biospecimens through the nation's first Lyme Disease Biobank, supports early-career scientists via the Emerging Leader Award program, conducts clinical trials through a partnership with UCSF, invests in diagnostics and therapeutics companies through Bay Area Lyme Ventures, and delivers prevention education and tick-borne disease awareness to the public.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Over $30M in grants awarded across 100+ projects from 37 institutions
+3 more records
Product overview1 text field

Bay Area Lyme Foundation operates as a nonprofit research accelerator focused on making Lyme disease easy to diagnose and simple to cure. The organization functions as a platform of interconnected programs: the Lyme Disease Biobank provides research samples to academic and industry researchers; the Emerging Leader Award provides grant funding to early-career scientists; Bay Area Lyme Ventures (launched 2025) invests in companies bringing diagnostics and therapeutics to market; the Clinical Trials Center at UCSF supports clinical development; and the Citizen Science Tick Testing Program engages the public in disease surveillance. Educational offerings include the Ticktective podcast/video series and an educational video library. Together, these programs form a comprehensive ecosystem supporting Lyme disease research from basic science through commercialization.

Product and service2 records
1Lyme Disease Biobank
CategoryResearch Resource / Biospecimen Services
Description

A national biospecimen repository that collects and distributes blood, urine, and tissue samples from Lyme disease patients and controls to support academic and industry research projects. The Biobank has distributed over 25,000 samples to support 125 approved research projects and contributed to FDA clearance of new Lyme diagnostic tests.

2Emerging Leader Award
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Project Lyme focuses on prevention and awareness. Since 2018, Bay Area Lyme's Science Committee became the research arm of Project Lyme. Each year they co-host the NYC Gala, with significant funds raised donated to Bay Area Lyme supporting science grants. To date Project Lyme has raised over $1.5M on behalf of Bay Area Lyme.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

In 2019, Bay Area Lyme Foundation, Alexandra Cohen, Project Lyme, and Laure Woods created Center for Lyme Action as a founding charter member to grow federal funding for Lyme disease. Bay Area Lyme serves as a charter member of this advocacy organization.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

NDRI partners with the Lyme Disease Biobank to obtain biospecimens from all body systems, enabling prospective procurement and project-specific collection protocols for biomedical research.

Strategic tierSupportingTypeGTM or Marketing Partner
Description

Partnership to provide tick-bite prevention education and training to California State Parks employees and the communities they serve through programs and materials.

Strategic tierSupportingTypeGTM or Marketing Partner
Description

Partnership for public organizations and community education providers to deliver tick-bite prevention information to employees and the communities they serve.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership with UCSF for conducting clinical trials on Lyme disease diagnostics and treatments, supporting the translation of research from laboratory to clinical application.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

National advocacy and education nonprofit focused on Lyme disease patient rights and research funding. Comparable disease-specific nonprofit operating in patient education and policy advocacy adjacent to Bay Area Lyme's mission.

2American Lyme Disease Foundation
TypeDirect peer
Description

Long-standing nonprofit focused on Lyme disease research, education, and prevention. Directly comparable disease-specific mission and educational outreach model to Bay Area Lyme Foundation.

TypeBroad incumbent
Description

Independent nonprofit supporting CDC's infectious disease work, including vector-borne illness surveillance. Operates as a much larger public-health grantmaking entity with overlapping missions in tick-borne disease prevention.

TypeDirect peer
Description

Major donor to Bay Area Lyme and a significant independent funder of Lyme disease research. Comparable philanthropic model with strong commitment to Lyme/tick-borne disease funding, making it both a partner and a parallel funder.

TypeBroad incumbent
Description

Professional medical society that funds and disseminates research across infectious diseases including Lyme. Broader scope but overlapping scientific advisory and clinical research community relevant to Bay Area Lyme's clinical and diagnostics programs.

TypeDirect peer
Description

Nonprofit focused on Lyme prevention and awareness whose Science Committee research arm is operated by Bay Area Lyme Foundation. Closely aligned mission and donor base; funds co-raised with Bay Area Lyme at the NYC Gala.

TypeDirect peer
Description

Another leading US-based nonprofit foundation dedicated exclusively to Lyme and tick-borne disease research, education, and patient support. Highly comparable mission, donor base, and grantmaking model to Bay Area Lyme Foundation.

TypeBroad incumbent
Description

Disease-specific nonprofit research accelerator that pioneered venture philanthropy and Biobank models in CF. Comparable in grantmaking-plus-impact-investing model and accelerating rare/infectious disease diagnostics and therapeutics to market.

TypeDirect peer
Description

Federal funding advocacy coalition co-founded by Bay Area Lyme and Project Lyme leadership. Comparable advocacy and policy mission aimed at growing federal tick-borne disease research appropriations.

10L.K. Whittier Foundation
TypeOthers
Description

Private foundation where Bay Area Lyme founder Laure Woods serves on the Board. Comparable grantmaking/charitable giving structure and overlapping board, though not disease-specific.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bay Area Lyme Foundation

Nonprofit Disease Research Foundationbayarealyme.org

Bay Area Lyme Foundation is a 501(c)(3) nonprofit founded in 2012 that funds Lyme disease research, operates the nation's first Lyme Disease Biobank, runs prevention education programs, and deploys impact investments through Bay Area Lyme Ventures to advance tick-borne disease diagnostics and therapeutics.

What Bay Area Lyme Foundation does

Bay Area Lyme Foundation is a 501(c)(3) nonprofit organization founded in 2012 and headquartered in Portola Valley, California. The foundation's mission is to make Lyme disease easy to diagnose and simple to cure by funding scientific research, operating research infrastructure, and providing prevention education. It serves Lyme disease patients, researchers at academic and industry institutions, healthcare providers, and the broader public affected by tick-borne illness — a population estimated at roughly 620,000 new US cases annually, with cases reported in 65 countries.

The foundation operates a vertically integrated research-acceleration platform spanning basic science funding, biospecimen distribution, clinical trials, and commercialization. Core programs include the Lyme Disease Biobank (the nation's first, with 25,000+ samples distributed to 125 approved research projects), the Emerging Leader Award grant program (grants ranging $150,000-$300,000), the UCSF-affiliated Clinical Trials Center, the Citizen Science Free Tick Testing Program, and educational content via the Ticktective podcast and video library. Since inception, the foundation has awarded over $30M in grants across more than 100 projects at 37 institutions and enabled FDA clearance for new diagnostic tests. In 2025 the foundation launched Bay Area Lyme Ventures, an impact investment arm that made its first strategic investment in Galaxy Diagnostics in June 2026.

Revenue is generated entirely through donations, grants, and event-based fundraising, with 100% of donor contributions directed to research and prevention because the LaureL Foundation covers all administrative expenses. Annual events include LymeAid (which raised $900,000 in 2026), Polo for Lyme, and Hops & Harmony. The organization is led by co-founders Laure L. Woods and Bonnie Crater as Co-Chairs of the Board, with David A. Walsey appointed Executive Director in 2025 succeeding Linda Giampa. Key strategic partners include the LaureL Foundation, Steven and Alexandra Cohen Foundation, Project Lyme, Center for Lyme Action, and NDRI.

Bay Area Lyme Foundation firmographics

Firmographics
Name
Bay Area Lyme Foundation
Legal name
Bay Area Lyme Foundation
Website
https://bayarealyme.org
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
1–10 employees
Short description
Bay Area Lyme Foundation is a 501(c)(3) nonprofit founded in 2012 that funds Lyme disease research, operates the nation's first Lyme Disease Biobank, runs prevention education programs, and deploys impact investments through Bay Area Lyme Ventures to advance tick-borne disease diagnostics and therapeutics.
Ownership category
akta.pro rank

Bay Area Lyme Foundation industry classification

Industry
Product category
Nonprofit Disease Research Foundation
NAICS
Grantmaking Foundations (813211), Voluntary Health Organizations (813212)
SIC
Services-Membership Organizations (8600)
akta.pro primary industry
Health & Medical Research Grantmaking Foundations (BPAGAKAL)
akta.pro secondary industry
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)

Keywords

  • Lyme disease research
  • Biospecimen biobank services
  • Research grant funding
  • Tick-borne disease prevention
  • Nonprofit health foundation

Where Bay Area Lyme Foundation is headquartered

Location

Headquarters

HQ city
Portola Valley
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Bay Area Lyme Foundation business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Others, Personnel, Marketing or Sales, Operations

Revenue model

  1. Donations and Grants: Bay Area Lyme Foundation operates as a 501(c)(3) nonprofit organization funded entirely through donations and grants. Thanks to the LaureL Foundation covering administrative expenses, 100% of donor contributions go directly to research and prevention programs.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels9 records

Bay Area Lyme Foundation product offering

Product offering

Core offering

Bay Area Lyme Foundation is a 501(c)(3) nonprofit foundation that funds Lyme disease research, distributes biospecimens through the nation's first Lyme Disease Biobank, supports early-career scientists via the Emerging Leader Award program, conducts clinical trials through a partnership with UCSF, invests in diagnostics and therapeutics companies through Bay Area Lyme Ventures, and delivers prevention education and tick-borne disease awareness to the public.

Product overview

Bay Area Lyme Foundation operates as a nonprofit research accelerator focused on making Lyme disease easy to diagnose and simple to cure. The organization functions as a platform of interconnected programs: the Lyme Disease Biobank provides research samples to academic and industry researchers; the Emerging Leader Award provides grant funding to early-career scientists; Bay Area Lyme Ventures (launched 2025) invests in companies bringing diagnostics and therapeutics to market; the Clinical Trials Center at UCSF supports clinical development; and the Citizen Science Tick Testing Program engages the public in disease surveillance. Educational offerings include the Ticktective podcast/video series and an educational video library. Together, these programs form a comprehensive ecosystem supporting Lyme disease research from basic science through commercialization.

Differentiator

Problem solved

Functional benefit

Brands

  • Lyme Disease Biobank: A biobank providing blood, urine, and tissue samples to researchers studying Lyme disease and tick-borne infections. Approaching 10-year anniversary with over 25,000 samples distributed to 125 approved research projects.
  • Bay Area Lyme Ventures
  • Ticktective
  • Emerging Leader Award
  • LymeAid

Products and services

  • Lyme Disease Biobank A national biospecimen repository that collects and distributes blood, urine, and tissue samples from Lyme disease patients and controls to support academic and industry research projects. The Biobank has distributed over 25,000 samples to support 125 approved research projects and contributed to FDA clearance of new Lyme diagnostic tests.
  • Emerging Leader Award

Quantifiable outcome

  • Over $30M in grants awarded across 100+ projects from 37 institutions
  • +3 more outcomes

Companies that use Bay Area Lyme Foundation

Customer profile

Named customers3 records

Segments1 record

Ideal customer profiles3 records

Bay Area Lyme Foundation technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Bay Area Lyme Foundation partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core, major, strategic and supporting.

  • Project LymecoreStrategic or Co-development PartnerProject Lyme focuses on prevention and awareness. Since 2018, Bay Area Lyme's Science Committee became the research arm of Project Lyme. Each year they co-host the NYC Gala, with significant funds raised donated to Bay Area Lyme supporting science grants. To date Project Lyme has raised over $1.5M on behalf of Bay Area Lyme.
  • Center for Lyme ActionmajorStrategic or Co-development PartnerIn 2019, Bay Area Lyme Foundation, Alexandra Cohen, Project Lyme, and Laure Woods created Center for Lyme Action as a founding charter member to grow federal funding for Lyme disease. Bay Area Lyme serves as a charter member of this advocacy organization.
  • National Disease Research Interchange (NDRI)strategicStrategic or Co-development PartnerNDRI partners with the Lyme Disease Biobank to obtain biospecimens from all body systems, enabling prospective procurement and project-specific collection protocols for biomedical research.
  • California State ParkssupportingGTM or Marketing PartnerPartnership to provide tick-bite prevention education and training to California State Parks employees and the communities they serve through programs and materials.
  • San Mateo County ParkssupportingGTM or Marketing PartnerPartnership for public organizations and community education providers to deliver tick-bite prevention information to employees and the communities they serve.
  • UCSF Clinical Trials CentercoreStrategic or Co-development PartnerPartnership with UCSF for conducting clinical trials on Lyme disease diagnostics and treatments, supporting the translation of research from laboratory to clinical application.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Bay Area Lyme Foundation competitors and assessment

Company assessment

Direct peers

  • LymeDisease.org: National advocacy and education nonprofit focused on Lyme disease patient rights and research funding. Comparable disease-specific nonprofit operating in patient education and policy advocacy adjacent to Bay Area Lyme's mission.
  • American Lyme Disease Foundation: Long-standing nonprofit focused on Lyme disease research, education, and prevention. Directly comparable disease-specific mission and educational outreach model to Bay Area Lyme Foundation.
  • Steven & Alexandra Cohen Foundation: Major donor to Bay Area Lyme and a significant independent funder of Lyme disease research. Comparable philanthropic model with strong commitment to Lyme/tick-borne disease funding, making it both a partner and a parallel funder.
  • Project Lyme: Nonprofit focused on Lyme prevention and awareness whose Science Committee research arm is operated by Bay Area Lyme Foundation. Closely aligned mission and donor base; funds co-raised with Bay Area Lyme at the NYC Gala.
  • Global Lyme Alliance: Another leading US-based nonprofit foundation dedicated exclusively to Lyme and tick-borne disease research, education, and patient support. Highly comparable mission, donor base, and grantmaking model to Bay Area Lyme Foundation.
  • Center for Lyme Action: Federal funding advocacy coalition co-founded by Bay Area Lyme and Project Lyme leadership. Comparable advocacy and policy mission aimed at growing federal tick-borne disease research appropriations.

Broad incumbents

  • CDC Foundation: Independent nonprofit supporting CDC's infectious disease work, including vector-borne illness surveillance. Operates as a much larger public-health grantmaking entity with overlapping missions in tick-borne disease prevention.
  • Infectious Diseases Society of America: Professional medical society that funds and disseminates research across infectious diseases including Lyme. Broader scope but overlapping scientific advisory and clinical research community relevant to Bay Area Lyme's clinical and diagnostics programs.
  • Cystic Fibrosis Foundation: Disease-specific nonprofit research accelerator that pioneered venture philanthropy and Biobank models in CF. Comparable in grantmaking-plus-impact-investing model and accelerating rare/infectious disease diagnostics and therapeutics to market.

Others

  • L.K. Whittier Foundation: Private foundation where Bay Area Lyme founder Laure Woods serves on the Board. Comparable grantmaking/charitable giving structure and overlapping board, though not disease-specific.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Bay Area Lyme Foundation social profiles

Digital presence

Bay Area Lyme Foundation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bay Area Lyme Foundation leadership team

Management profile

Number of profiles

Profiles10 records

Bay Area Lyme Foundation subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Bay Area Lyme Foundation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bay Area Lyme Foundation M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bay Area Lyme Foundation

What does Bay Area Lyme Foundation do?

Bay Area Lyme Foundation is a 501(c)(3) nonprofit foundation that funds Lyme disease research, distributes biospecimens through the nation's first Lyme Disease Biobank, supports early-career scientists via the Emerging Leader Award program, conducts clinical trials through a partnership with UCSF, invests in diagnostics and therapeutics companies through Bay Area Lyme Ventures, and delivers prevention education and tick-borne disease awareness to the public.

Is Bay Area Lyme Foundation a public or private company?

Bay Area Lyme Foundation is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Bay Area Lyme Foundation founded?

Bay Area Lyme Foundation was founded in 2012. It employs 1 to 10 people.

Where is Bay Area Lyme Foundation based?

Bay Area Lyme Foundation is headquartered in Portola Valley, United States, in the North America region.

How does Bay Area Lyme Foundation make money?

One revenue line is on record: donations and Grants.

Who are Bay Area Lyme Foundation's main competitors?

Direct peers on record are LymeDisease.org, American Lyme Disease Foundation, Steven & Alexandra Cohen Foundation, Project Lyme, Global Lyme Alliance and Center for Lyme Action. Broad incumbents are CDC Foundation, Infectious Diseases Society of America and Cystic Fibrosis Foundation. L.K. Whittier Foundation is listed as an others.

Does Bay Area Lyme Foundation have an API?

No public API is recorded for Bay Area Lyme Foundation.

What industry is Bay Area Lyme Foundation in?

Bay Area Lyme Foundation's product category is Nonprofit Disease Research Foundation. Its primary akta.pro industry code is BPAGAKAL, Health & Medical Research Grantmaking Foundations, with a secondary code of BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS). Its NAICS code is 813211 and its SIC code is 8600.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Current NewsUVM disease specialist receives national grant to advance tick-borne researchPeter Hyson, M.D. from the University of Vermont received a $150,000 Emerging Leader Award from the Bay Area Lyme Foundation to advance research into babesiosis, a tick-borne blood infection caused by microscopic parasites that destroy red blood cells. With approximately 60% of blacklegged ticks in Vermont testing positive for tick-borne diseases, Dr. Hyson has identified a promising new class of drug compounds and is working to confirm their target for therapy development. If successful, this would represent the first drug created specifically for babesiosis treatment, as existing standard-of-care medicines are inadequate and can lead to relapsing cases.GlobeNewswireNew Bay Area Lyme Foundation Study Shows Common FDA-Cleared Lyme Tests Miss 64-78% of Early Cases, Underscores Urgent Need for Improved DiagnosticsA study from the Bay Area Lyme Foundation found that common FDA-cleared Lyme tests miss 64-78% of early Lyme disease cases, including those with the characteristic rash. Only 39% of 107 early cases were positive by any of the four testing algorithms. The authors urge improved diagnostics that directly detect the bacteria.GlobeNewswireNew Peer-Reviewed Publication Highlights Evidence of Mother-to-Child-Transmission of Lyme Disease Bacteria During Pregnancy and Calls for Urgent ResearchA new peer-reviewed article published in Frontiers in Medicine by researchers affiliated with Bay Area Lyme Foundation reviews evidence that Lyme Borrelia bacteria can be transmitted from mother to unborn child during pregnancy, with the CDC and NIH recognizing this potential transmission risk. The publication, stemming from a scientific convening at the Banbury Center of Cold Spring Harbor Laboratory funded by the Steven & Alexandra Cohen Foundation, calls for urgent large-scale prospective studies to quantify outcomes and understand the mechanisms of transmission. With approximately 500,000 Americans diagnosed with Lyme disease annually and associated adverse pregnancy outcomes including miscarriage, stillbirth, and congenital infection, the authors emphasize this remains an understudied public health issue despite evidence dating back to the 1980s.BioSpaceNew Peer-Reviewed Publication Highlights Evidence of Mother-to-Child-Transmission of Lyme Disease Bacteria During Pregnancy and Calls for Urgent ResearchA new peer-reviewed paper in Frontiers in Medicine reports observational evidence of Lyme disease bacteria transmission from mother to unborn child, citing CDC and NIH recognition. The paper highlights the need for large prospective studies and biorepositories to clarify risks and outcomes.BioSpaceBay Area Lyme Foundation Highlights Research Leadership and Momentum in Tick-Borne Disease, Names New Executive DirectorBay Area Lyme Foundation announced significant progress in 2025 including FDA clearance for new diagnostic tests enabled by their Lyme Disease Biobank, along with the launch of Bay Area Lyme Ventures, an investment arm designed to accelerate diagnostics and therapeutics from laboratory to real-world use. The organization also named David A. Walsey, who brings over 25 years of biotechnology experience and personal connection to Lyme disease, as its new Executive Director. This milestone comes as the Lyme Disease Biobank approaches its 10-year anniversary, having distributed over 25,000 samples to support 125 approved academic and industry research projects.GlobeNewswireBay Area Lyme Foundation Highlights Research Leadership and Momentum in Tick-Borne Disease, Names New Executive DirectorBay Area Lyme Foundation announced David A. Walsey as Executive Director and highlighted 2025 progress, including FDA clearance of new diagnostics from its Lyme Disease Biobank. The foundation has invested over $30 million in research, supporting 70+ publications and 125 projects. Walsey aims to close gaps in patient care, with 2026 marking 10 years of Biobank operation.GlobeNewswireBacterial Mechanism That Could Help Prevent and Treat Lyme Arthritis Identified by New Bay Area Lyme Foundation–Supported StudyResearchers identified a mechanism in Borrelia burgdorferi peptidoglycan that triggers Lyme arthritis, published in PLOS Pathogens. Altering the peptidoglycan structure nearly eliminated joint inflammation in preclinical models, suggesting new therapeutic approaches independent of antibiotics.GlobeNewswireBay Area Lyme Foundation Launches Bay Area Lyme Ventures as First Impact Investment Fund to Support Entrepreneurs and Companies Advancing Lyme Disease SolutionsBay Area Lyme Foundation launched Lyme Ventures, an impact fund to invest in Lyme disease diagnostics and therapeutics. It announced investments in Aces Diagnostics and LymeAlert, with a $5 million investment goal by 2027. The fund aims to translate research into commercial solutions for patients.GlobeNewswireBay Area Lyme Foundation Launches Bay Area Lyme Ventures as First Impact Investment Fund to Support Entrepreneurs and Companies Advancing Lyme Disease SolutionsBay Area Lyme Foundation launched Lyme Ventures, an impact fund to invest in Lyme disease diagnostics and therapeutics. It announced investments in Aces Diagnostics and LymeAlert, with a $5 million investment goal by 2027. The fund aims to translate research into commercial solutions.GlobeNewswireBay Area Lyme Foundation Launches Bay Area Lyme Ventures as First Impact Investment Fund to Support Entrepreneurs and Companies Advancing Lyme Disease SolutionsBay Area Lyme Foundation launched Lyme Ventures, an impact fund to invest in Lyme disease diagnostics and therapeutics. It announced investments in Aces Diagnostics and LymeAlert, with a $5 million investment goal by 2027. The fund aims to translate research into commercial solutions for patients.